Format

Send to

Choose Destination
See comment in PubMed Commons below
BMJ. 2006 Mar 18;332(7542):632-6. Epub 2006 Feb 8.

Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial.

Author information

1
University of Liverpool Division of Child Health, Royal Liverpool Children's Hospital, Liverpool L12 2AP.

Abstract

OBJECTIVE:

To determine whether oral protein energy supplements, used long term in children with cystic fibrosis who are moderately malnourished, improve nutritional and other outcomes.

DESIGN:

Multicentre randomised controlled trial.

SETTING:

Seven specialist paediatric cystic fibrosis centres and their associated shared care clinics and seven smaller paediatric cystic fibrosis clinics.

PARTICIPANTS:

102 children with cystic fibrosis, aged between 2 and 15 years, who were moderately malnourished.

INTERVENTIONS:

Oral protein energy supplements in addition to usual dietary advice compared with dietary advice alone, for 12 months.

MAIN OUTCOME MEASURE:

Change in body mass index centile over one year.

RESULTS:

Use of supplements was not associated with a change in body mass index centile (mean difference 2.99 centile points, 95% confidence interval -2.70 to 8.68) or other nutritional and spirometric outcomes in this group of children.

CONCLUSIONS:

Long term use of oral protein energy supplements did not result in an improvement in nutritional status or other clinical outcomes in children with cystic fibrosis who were moderately malnourished. Oral protein energy supplements should not be regarded as an essential part of the management of this group of children.

TRIAL REGISTRATION:

ISRCTN: 95744468.

PMID:
16467348
PMCID:
PMC1403226
DOI:
10.1136/bmj.38737.600880.AE
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center